Detailed information for compound 1432504

Basic information

Technical information
  • TDR Targets ID: 1432504
  • Name: 3-(4-chlorophenyl)-1-methyl-1-(2-pyridin-2-yl ethyl)urea
  • MW: 289.76 | Formula: C15H16ClN3O
  • H donors: 1 H acceptors: 2 LogP: 2.66 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: Clc1ccc(cc1)NC(=O)N(CCc1ccccn1)C
  • InChi: 1S/C15H16ClN3O/c1-19(11-9-13-4-2-3-10-17-13)15(20)18-14-7-5-12(16)6-8-14/h2-8,10H,9,11H2,1H3,(H,18,20)
  • InChiKey: MHIOAEPGOGUZPB-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 3-(4-chlorophenyl)-1-methyl-1-[2-(2-pyridyl)ethyl]urea
  • Oprea1_583016
  • MLS000564973
  • SMR000152232

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Influenza A virus Nonstructural protein 1 Starlite/ChEMBL No references
Homo sapiens nuclear factor, erythroid 2-like 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Mycobacterium tuberculosis Hypothetical protein Nonstructural protein 1   230 aa 202 aa 23.8 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni hypothetical protein 0.0051 0.0081 0.0025
Schistosoma mansoni phosphoglycerate mutase 0.0051 0.0081 0.0025
Loa Loa (eye worm) hypothetical protein 0.0051 0.0081 0.0081
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0051 0.0081 0.5
Giardia lamblia Hypothetical protein 0.1784 0.5865 0.5
Schistosoma mansoni hypothetical protein 0.0051 0.0081 0.0025
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0051 0.0081 0.5
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0051 0.0081 0.5
Plasmodium vivax phosphoglucomutase-2, putative 0.0051 0.0081 0.5
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.129 0.4216 0.4169
Toxoplasma gondii phosphoglycerate mutase PGMII 0.0051 0.0081 0.5
Echinococcus granulosus phosphoglycerate mutase 0.0051 0.0081 0.0025
Loa Loa (eye worm) hypothetical protein 0.3024 1 1
Schistosoma mansoni hypothetical protein 0.0051 0.0081 0.0025
Loa Loa (eye worm) phosphoglycerate mutase 0.0051 0.0081 0.0081
Loa Loa (eye worm) hypothetical protein 0.0051 0.0081 0.0081
Echinococcus multilocularis serine:threonine protein phosphatase PGAM5 0.0051 0.0081 0.0025
Mycobacterium leprae probable isochorismate synthase EntC 0.0051 0.0081 0.5
Toxoplasma gondii phosphoglycerate mutase family protein 0.0051 0.0081 0.5
Plasmodium vivax phosphoglycerate mutase, putative 0.0051 0.0081 0.5
Loa Loa (eye worm) hypothetical protein 0.1733 0.5695 0.5695
Echinococcus granulosus phosphoglycerate mutase 0.0051 0.0081 0.0025
Echinococcus multilocularis phosphoglycerate mutase 0.0051 0.0081 0.0025
Echinococcus multilocularis serine:threonine protein phosphatase PGAM5 0.0051 0.0081 0.0025
Schistosoma mansoni 6-phosphofructokinase 0.3024 1 1
Mycobacterium leprae PROBABLE PHOSPHOGLYCERATE MUTASE (PHOSPHOGLYCEROMUTASE) 0.0051 0.0081 0.5
Chlamydia trachomatis 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase 0.0051 0.0081 0.5
Giardia lamblia Hypothetical protein 0.1784 0.5865 0.5
Loa Loa (eye worm) hypothetical protein 0.0051 0.0081 0.0081
Loa Loa (eye worm) hypothetical protein 0.2973 0.983 0.983
Mycobacterium leprae POSSIBLE HYDROLASE MUTT1 0.0051 0.0081 0.5
Schistosoma mansoni hypothetical protein 0.0051 0.0081 0.0025
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.129 0.4216 0.4169
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0081 0.5
Mycobacterium leprae conserved hypothetical protein 0.0051 0.0081 0.5
Entamoeba histolytica phosphoglycerate mutase family protein, putative 0.0051 0.0081 0.0044
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.2973 0.983 0.9828
Mycobacterium leprae Probable phosphoglycerate mutase (phosphoglyceromutase) (phosphoglycerate phosphomutase) 0.0051 0.0081 0.5
Trypanosoma cruzi 6-phosphofructo-2-kinase 1 0.2973 0.983 0.9828
Schistosoma mansoni phosphoglycerate mutase 0.0051 0.0081 0.0025
Mycobacterium tuberculosis Probable oxidoreductase 0.0918 0.2975 1
Trypanosoma brucei 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.3024 1 1
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0051 0.0081 0.5
Toxoplasma gondii phosphoglycerate mutase 0.0051 0.0081 0.5
Mycobacterium ulcerans hypothetical protein 0.1784 0.5865 1
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.3024 1 1
Schistosoma mansoni hypothetical protein 0.0051 0.0081 0.0025
Brugia malayi hypothetical protein 0.0043 0.0056 0.6888
Echinococcus granulosus phosphoglycerate mutase 0.0051 0.0081 0.0025
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.2973 0.983 0.9828
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.129 0.4216 0.4169
Trypanosoma brucei 6-phosphofructo-2-kinase 2 0.2973 0.983 0.9828
Trichomonas vaginalis conserved hypothetical protein 0.0051 0.0081 0.5
Echinococcus granulosus serine:threonine protein phosphatase PGAM5 0.0051 0.0081 0.0025
Toxoplasma gondii phosphoglycerate mutase family protein 0.0051 0.0081 0.5
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein 0.129 0.4216 0.4169
Echinococcus multilocularis phosphoglycerate mutase 0.0051 0.0081 0.0025
Echinococcus granulosus phosphoglycerate mutase 0.0051 0.0081 0.0025
Brugia malayi phosphoglycerate mutase family protein 0.0051 0.0081 1
Plasmodium falciparum phosphoglycerate mutase, putative 0.0051 0.0081 0.5
Echinococcus multilocularis phosphoglycerate mutase 0.0051 0.0081 0.0025
Entamoeba histolytica phosphoglycerate mutase family protein. putative 0.0051 0.0081 0.0044
Echinococcus multilocularis phosphoglycerate mutase 0.0051 0.0081 0.0025
Mycobacterium ulcerans fructose-2,6-bisphosphatase GpmB 0.1784 0.5865 1
Echinococcus multilocularis phosphoglycerate mutase 0.0051 0.0081 0.0025
Brugia malayi phosphoglycerate mutase family protein 0.0051 0.0081 1
Trypanosoma cruzi 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.3024 1 1
Mycobacterium leprae conserved hypothetical protein 0.0051 0.0081 0.5
Onchocerca volvulus 0.3024 1 1
Treponema pallidum phosphoglyceromutase 0.0051 0.0081 0.5
Schistosoma mansoni hypothetical protein 0.0051 0.0081 0.0025
Mycobacterium ulcerans short chain dehydrogenase 0.0918 0.2975 0.5003
Leishmania major 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative 0.3024 1 1
Toxoplasma gondii phosphoglycerate mutase family protein 0.0051 0.0081 0.5
Plasmodium falciparum phosphoglucomutase-2 0.0051 0.0081 0.5
Toxoplasma gondii phosphoglycerate mutase family protein 0.0051 0.0081 0.5
Echinococcus multilocularis 6 phosphofructo 2 kinase:fructose 2 0.3024 1 1
Brugia malayi UBASH3A protein homolog 0.0051 0.0081 1
Trichomonas vaginalis phosphoglycerate mutase, putative 0.0051 0.0081 0.5
Loa Loa (eye worm) hypothetical protein 0.0051 0.0081 0.0081
Mycobacterium leprae Possible phosphoglycerate mutase 0.0051 0.0081 0.5
Echinococcus granulosus phosphoglycerate mutase 0.0051 0.0081 0.0025
Echinococcus granulosus serine:threonine protein phosphatase PGAM5 0.0051 0.0081 0.0025
Mycobacterium leprae conserved hypothetical protein 0.0051 0.0081 0.5
Echinococcus multilocularis phosphoglycerate mutase 0.0051 0.0081 0.0025
Entamoeba histolytica phosphoglycerate mutase family protein, putative 0.1784 0.5865 1
Mycobacterium leprae PROBABLE PHOSPHOGLYCERATE MUTASE 1 GPM1 (PHOSPHOGLYCEROMUTASE) (PGAM) (BPG-DEPENDENT PGAM) 0.0051 0.0081 0.5
Entamoeba histolytica phosphoglycerate mutase family protein, putative 0.0051 0.0081 0.0044

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 3.2944 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 5.8048 uM PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] ChEMBL. No reference
Potency (functional) = 11.2202 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 13.1154 uM PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] ChEMBL. No reference
Potency (functional) 26.8545 uM PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Plasmodium falciparum ChEMBL23

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.